Topics

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.


If no search results for your keyword(s) were found, you are encouraged to review Agency omnibus solicitations for additional funding opportunities. Omnibus solicitations are structured to be broad, extensive Programmatic issuances with research areas related to the petitioning Agency and are not limited to predetermined Topics/Subtopics. If upon reviewing you have additional questions, you may consider reaching out to the respective Agency for clarification regarding acceptable proposals (https://www.sbir.gov/agency-contacts).

  1. PAR-17-108: Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)

    Release Date: 01-09-2017Open Date: 03-05-2017 Due Dates: Multiple Close Date: 04-05-2020

    The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) research and development of next-generation socially-assistive robots (SARs) to enhance health and well-being, reduce illness and disability, and improve quality of life for individuals with Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD), and for caregiver ...

    SBIRPhase IDepartment of Health and Human Services
  2. PAR-17-107 : Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42)

    Release Date: 01-09-2017Open Date: 03-05-2017 Due Dates: Multiple Close Date: 04-05-2020

    The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Technology Transfer (STTR) research and development of next-generation socially-assistive robots (SARs) to enhance health and well-being, reduce illness and disability, and improve quality of life for individuals with Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD), and for caregiver ...

    STTRPhase IDepartment of Health and Human Services
  3. PAR-18-186: Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)

    Release Date: 11-28-2017Open Date: 03-06-2018 Due Dates: Multiple Close Date: 04-05-2020

    The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) research and development of next-generation socially-assistive robots (SARs) to enhance health and well-being, reduce illness and disability, and improve quality of life for individuals with Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD), and for c ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  4. PAR-18-185 : Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)

    Release Date: 11-28-2017Open Date: 03-06-2018 Due Dates: Multiple Close Date: 04-06-2020

    The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Technology Transfer (STTR) research and development of next-generation socially-assistive robots (SARs) to enhance health and well-being, reduce illness and disability, and improve quality of life for individuals with Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD), and for c ...

    STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  5. PA-19-272: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

    Release Date: 05-07-2019Open Date: 08-05-2019 Due Dates: Multiple Close Date: 04-06-2020

    The SBIR program, as established by law, is intended to meet the following goals: stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs; increase the commercial application of Federally-supported research results; foster and encourage participation by socially and economically disadvanta ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  6. PA-19-273: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

    Release Date: 05-07-2019Open Date: 08-05-2019 Due Dates: Multiple Close Date: 04-06-2020

    The SBIR program, as established by law, is intended to meet the following goals: stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs; increase the commercial application of Federally-supported research results; foster and encourage participation by socially and economically disadvanta ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  7. PA-19-270: PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed

    Release Date: 05-07-2019Open Date: 08-05-2019 Due Dates: Multiple Close Date: 04-06-2020

    The STTR program, as established by law, is intended to stimulate a partnership of ideas and technologies between innovative small business concerns (SBCs) and non-profit research institutions through Federally-funded research or research and development (R/R&D). By providing awards to SBCs for cooperative R/R&D efforts with non-profit research institutions, the STTR program assists the small busi ...

    STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  8. PA-19-271: PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required

    Release Date: 05-07-2019Open Date: 08-05-2019 Due Dates: Multiple Close Date: 04-07-2020

    The STTR program, as established by law, is intended to stimulate a partnership of ideas and technologies between innovative small business concerns (SBCs) and non-profit research institutions through Federally-funded research or research and development (R/R&D). By providing awards to SBCs for cooperative R/R&D efforts with non-profit research institutions, the STTR program assists the small busi ...

    STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  9. PAR-17-201 : Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

    Release Date: 03-09-2017Open Date: 07-09-2017 Due Dates: Multiple Close Date: 05-07-2020

    A. Overview Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, before a new chemical entity can be tested in a clinical setting, it must undergo a process of chemical optimization to improve potency, selectivity, and drug-like properties, followed by pre-clinical safety testing to meet the standards set by the Food an ...

    SBIRPhase IDepartment of Health and Human Services
  10. PAR-18-541 : Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

    Release Date: 12-21-2017Open Date: 01-07-2018 Due Dates: Multiple Close Date: 05-07-2020

    A. Overview Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, before a new chemical entity can be tested in a clinical setting, it must undergo a process of chemical optimization to improve potency, selectivity, and drug-like properties, followed by pre-clinical safety testing to meet the standards set by the Food ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government